Your trusted destination for CME, CPD & Medical Education across the Middle East.
Insilico Medicine
Dr. Alex Zhavoronkov is a scientist, entrepreneur, and internationally recognised leader in artificial intelligence (AI), biotechnology, and longevity research. He is the founder and CEO of Insilico Medicine, a clinical-stage biotechnology company developing AI-powered technologies for drug discovery, biomarker development, and research into age-related diseases.
Dr. Zhavoronkov holds two bachelor's degrees from Queen’s University in Canada, a master's degree in biotechnology from Johns Hopkins University, and a PhD in physics and mathematics from Moscow State University. His multidisciplinary background combines biomedical research, computational science, and technology, allowing him to explore the application of advanced AI methods to complex biological and medical challenges.
In 2014, he founded Insilico Medicine with the goal of accelerating drug discovery through computational biology and artificial intelligence. He helped pioneer the use of generative adversarial networks and reinforcement learning to identify potential drug targets and generate novel molecular structures with desired properties. Under his leadership, the company has expanded its international research operations, developed partnerships with pharmaceutical and academic institutions, and advanced AI-discovered drug candidates into clinical development.

dmg events
dmg events